IV Reunión HOPE Iberia
The HOPe-volution: expandiendo las fronteras de la perfusión hipotérmica oxigenada
Vall d’Hebron Institut de Recerca, Barcelona, Spain
Thursday, March 26th,2026 10:00–17:00
¿Por qué asistir?
Esta jornada ofrece una visión integral y actualizada sobre la perfusión hipotérmica oxigenada (HOPE) en el trasplante hepático, abordando desde la práctica clínica real y el análisis profundo de datos hasta la expansión de indicaciones, la optimización del injerto y la innovación quirúrgica. Los asistentes conocerán experiencias consolidadas de centros de referencia en Iberia y Europa, debatirán sobre la ampliación de criterios en donantes DCD y de criterios ampliados, y explorarán el papel de HOPE como estándar de cuidado en distintos escenarios clínico
Orden del día
The HOPe-volution: expandiendo las fronteras de la perfusión hipotérmica oxigenada; 4ª Jornada HOPE Iberia – Trasplante Hepático
Práctica actual con HOPE: experiencia clínica y datos
Moderador: Hospital Universitario Vall d’Hebron
Perfusión Hipotérmica Oxigenada en España – Análisis de datos
Dr. Lluís Secanella, Hospital Universitario Bellvitge, Barcelona
HOPE en injertos estándares: La experiencia de Coímbra
Dr. Dulce Diogo, Centro Hospitalar e Universitário de Coimbra, Coimbra
Impacto económico de HOPE: Costes, recursos y sostenibilidad
Russell Bolton, Queen Elizabeth Hospital Birmingham, UK
Indicaciones actuales y futuras de HOPE – Debate
Moderador: Hospital Universitario Vall d’Hebron
Combinación PRN y HOPE
Dr.Sergio Cortese, Hospital Universitario Gregorio Marañón, Madrid
HOPE para hepatocarcinoma (HCC)
Dr. Maria João Amaral, Centro Hospitalar e Universitário de Coimbra, Coimbra
HOPE y efecto inmunomodulador y rechazo
Dr. Marco Maria Pascale, Policlinico Universitario Agostino Gemelli, Rome, Italy
Perfusión prolongada
Dr. Rebeca Sanabria, QEH, Birmingham Queen Elizabeth Hospital Birmingham, UK
Discusión y preguntas (Q&A)
HOPE: Aplicaciones técnicas y quirúrgicas
Moderador: Hospital Universitario Vall d’Hebron
Split ex-situ y reducciones de injerto con HOPE como el nuevo estándar: Resultados pediátricos y españoles
Dr. Maria Velayos, Hospital Universitario La Paz, Madrid
Rol de enfermeria y/o perfusionistas durante HOPE
Sandra Torres, Hospital Universitario Vall d’Hebron, Barcelona
Cirugía de banco asistida por HOPE
Dr. Arkaitz Perfecto, Hospital Universitario Cruces, Bilbao
Innovación quirúrgica: HOPE para facilitar el trasplante hepático robótico
Dr. Hugo Pinto Marques (remote), Hospital Curry Cabral, Lisboa
Dr. Silvía Gomes Da Silva (in person), Hospital Curry Cabral, Lisboa
Resección in-situ bajo perfusión HOPE
Dr. Gonzalo Sapisochin, Hospital Universitario Vall d´Hebron, Barcelona
Evaluación de viabilidad durante la perfusión hipotérmica oxigenada – Actualización
Dr. Mireia Caralt, Vall d’Hebron University Hospital, Barcelona
Dr. Óscar Caso, Hospital Universitario Doce de Octubre, Madrid
Additional Information
-
MasterClass venue is an approximate 10 minute cab ride from the nearest train station.
-
Unreserved parking is available on site.
-
Thackray Museum of Medicine information
-
Nearby Accommodations
-
Leeds information
Speakers

Barbara Fiore
Leeds
Bio

Rod Figueiredo
Newcastle
Bio

Samuel James Tingle, MD (PhD Candidate)
Newcastle University in Newcastle upon Tyne, England, School of Biomedical Sciences
Dr. Tingle is a surgeon and PhD candidate at Newcastle University. He is a Specialist Registrar in Surgery and an MRC Clinical Research Fellow in Transplantation. Dr. Tingle has maintained a relationship with the transplantation team at the Freeman Hospital since medical school, facilitating his continual involvement in multiple laboratory-based, translational and clinical research projects throughout his MRes, Academic Foundation Programme and Academic Clinical Fellowship. His research interests include machine perfusion, registry analysis, big data and meta-analysis.
Dr. Tingle is currently a Medical Research Council Clinical Research Fellow and Cochrane Clinical Answers Associate Editor. He is a member of the Royal College of Surgeons. Dr. Tingle is the recipient of the North East Surgical Training Academy NESTAC Medal for oral presentation of research, and is the recipient of several research grants, including most recently MRC Clinical Research Training Fellowship, with joint Kidney Research UK funding, the Wellcome Trust Translational Partnership – Early Translational Funding and Quality in Organ Donation Research Grant.
Dr. Tingle’s first-author publications include Donor Liver Blood Tests and Liver Transplant Outcomes: UK Registry Cohort Study, Transplantation, and Machine perfusion in liver transplantation. Cochrane Database of Systematic Reviews.

Philipp Dutkowski Prof. Dr. Med.
Professor of Surgery, Deputy Head of Visceral Surgery
University Hospital Basel, Switzerland
Philipp Dutkowski, MD is currently Professor of Surgery at the University Hospital Basel, Switzerland where he recently joined to start their liver transplant program. Prior to this appointment, he was Head of Abdominal Organ Transplantation and Director of the Liver Transplant Program in Zurich. He started his surgical career in 1993 in Germany at the University of Mainz, and completed his board certification for Surgery in 1999, and for Visceral Surgery in 2002. In parallel, he completed his thesis for Habilitation in 2001, after establishing a research group in the field of liver preservation. In 2004, he joined the group of Pierre Alain Clavien in Zurich, and succeeded to translate basic research on machine liver perfusion into clinical application. Since 2009, he leads the abdominal transplant program in Zurich.

David Nasralla
Royal Free
Bio

Keziah Crick
Royal Free
Bio

Colin Wilson
Newcastle
Bio
Registration is Free. Delegates will need to cover their own travel and accommodation costs.
